Results of a small, but unique research study, led by researchers from the Seaver Autism Center for Research and Treatment at Mount Sinai and published...
Acting out your dreams could be a sign of a neurological disease, a study finds ASX-listed Pharmaxis to launch a ... Read More The post This...
Mydecine Innovations Group is a next-generation biotechnology company that is no stranger to headlines. From their inception in 2020, they have made quite...
CURE Pharmaceutical Holding Corp. (OTC: CURR), a proprietary broad platform and wellness technology company, today announced results for the quarter ended June...
Influencing policies, cataloguing proof of efficacy and assisting veterans integration processes will be ideal outcomes from partnership The post Heroic...
Amidst the ongoing biotech market slowdown, companies are trying various ways to stay afloat. Some are going public, and some are taking on debt. The newest...